Document is current
Any future updates will be listed below
-
Authors
Chung, Clive Yik-Sham
Shin, Hijai R.
Berdan, Charles A.
Ford, Breanna https://orcid.org/0000-0001-8277-9406
Ward, Carl C.
Olzmann, James A. https://orcid.org/0000-0001-7751-8316
Zoncu, Roberto https://orcid.org/0000-0003-1611-1891
Nomura, Daniel K. https://orcid.org/0000-0003-1614-8360
- License Information
-
More Information
Article History
Received: 15 January 2019
Accepted: 15 May 2019
First Online: 8 July 2019
Competing interests
: This study was funded by the Novartis Institutes for BioMedical Research and the Novartis-Berkeley Center for Proteomics and Chemistry Technologies. D.K.N. is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies. D.K.N. is a co-founder, share-holder and adviser for Artris Therapeutics and Frontier Medicines. R.Z. is a co-founder, share-holder and adviser for Frontier Medicines.
